| Product NDC: | 51079-869 |
| Proprietary Name: | Verapamil Hydrochloride |
| Non Proprietary Name: | verapamil hydrochloride |
| Active Ingredient(s): | 240 mg/1 & nbsp; verapamil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51079-869 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074587 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120712 |
| Package NDC: | 51079-869-56 |
| Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-869-56) > 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (51079-869-30) |
| NDC Code | 51079-869-56 |
| Proprietary Name | Verapamil Hydrochloride |
| Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-869-56) > 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (51079-869-30) |
| Product NDC | 51079-869 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | verapamil hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120712 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Strength Number | 240 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |